Страна: Ирландия
Език: английски
Източник: HPRA (Health Products Regulatory Authority)
CARPROFEN
Norbrook Laboratories Limited
QM01AE91
CARPROFEN
100 Milligram
Tablets
POM
Canine
Carprofen
N.S.A.I.D
Authorised
2010-11-26
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Carprogesic 100 mg Tablets for Dogs. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Tablet. A yellow circular tablet of 8 mm diameter, embossed “100” on one side and a single breakline on the other side. The tablets can be divided into halves. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In the dog: Reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease. As a follow up to parenteral analgesia in the management of post operative pain. 4.3 CONTRAINDICATIONS Do not use in cats. Do not use in pregnant or lactating bitches. Do not use in puppies less than 4 months of age. Do not use in animals with known hypersensitivity to the active substance or to any of the excipients Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding, or where there is evidence of a blood dyscrasia. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Refer to Sections 4.3 and 4.5. Each tablet contains: Active Ingredient: Carprofen 100 mg Excipients: Tartrazine (E102) 1.2 mg For the full list of excipients, see Section 6.1 HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 12/09/2014_ _CRN 7015354_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Use in aged dogs may involve additional risk. If such a use cannot be avoided, such dogs may require a reduced dosage and careful clinical management. Avoid use in any dehydrated, hypoproteinemic, hypovolaemic or hypotensive dog, as there is a po Прочетете целия документ